Prelude Capital Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$339K Buy
+84,648
New +$339K 0.03% 563
2024
Q2
Sell
-62,445
Closed -$478K 1255
2024
Q1
$478K Buy
+62,445
New +$478K 0.03% 586